Shopping Cart
- Remove All
- Your shopping cart is currently empty
Bryonolic acid (20-epi-Bryonolic acid), a triterpenoid extracted from Sandoricum indicum, possesses immunomodulatory, anti-inflammatory, antioxidant and anticancer activities and protects PC12 cells from NMDA-induced apoptosis by inhibiting Ca2+ in-flux and modulating gene expression in the Ca2+-CaMKII-CREB signalling pathway.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $316 | In Stock | |
2 mg | $468 | In Stock | |
5 mg | $769 | In Stock |
Description | Bryonolic acid (20-epi-Bryonolic acid), a triterpenoid extracted from Sandoricum indicum, possesses immunomodulatory, anti-inflammatory, antioxidant and anticancer activities and protects PC12 cells from NMDA-induced apoptosis by inhibiting Ca2+ in-flux and modulating gene expression in the Ca2+-CaMKII-CREB signalling pathway. |
Targets&IC50 | M2 mAChR:7.78 (pKi), M1 mAChR:7.08 (pKi), H1 Receptor:7.48 (pA2), mAChR4:7.00 (pKi), M3 mAChR:6.70 (pKi) |
In vitro | In the presence of three elicitors (methyl jasmonate, yeast extract, and chitosan), cell suspensions treated with 1 mg/mL of chitosan for eight days led to higher bryonolic acid contents (23.56 ± 1.68 mg/g dry weight),cell culture and root extracts with high bryonolic acid contents resulted in significantly higher percent cell viabilities than those observed under control (1% v/v DMSO) treatment in Saos-2 and MCF-7 cells[1]. Bryonolic acid inhibits ACAT in intact cancer cells with an IC50 of 12.6 ± 2.4 µM.Bryonolic acid inhibited both clonogenicity and invasiveness of several cancer cell lines[2]. |
In vivo | Treatment with 500 mg/kg Bryonolic acid or vehicle by intraperitoneal injection in Nrf2 wild-type or Nrf2 knockout mice revealed that Bryonolic acid effectively induced HO-1 in a manner dependent on the Nrf2-Keap1 pathway[3]. |
Alias | UNII-J7YR6A878I, 20-epi-Bryonolic acid |
Molecular Weight | 456.7 |
Formula | C30H48O3 |
Cas No. | 24480-45-3 |
Smiles | C[C@@]12[C@](C)([C@]3([C@@](C)(CC1)CC[C@@](C(O)=O)(C)C3)[H])CCC4=C2CC[C@@]5([C@]4(C)CC[C@H](O)C5(C)C)[H] |
Relative Density. | 1.10 g/cm3 (Predicted) |
Storage | keep away from direct sunlight,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||
Solubility Information | DMSO: 1 mg/mL (2.19 mM), Sonication is recommended. | ||||||||||
Solution Preparation Table | |||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.